In breast invasive carcinoma, lung squamous cell carcinoma, prostate adenocarcinoma, and kidney renal papillary cell carcinoma, CXCR2 ligands negatively correlated with EMT but positively correlated with lymph node metastasis. Here, CXCR2 is linked to prostate adenocarcinoma.